137 related articles for article (PubMed ID: 31494469)
21. Synthesis of a series of novel dihydroartemisinin monomers and dimers containing chalcone as a linker and their anticancer activity.
Gaur R; Pathania AS; Malik FA; Bhakuni RS; Verma RK
Eur J Med Chem; 2016 Oct; 122():232-246. PubMed ID: 27371926
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of novel 2,3-dihydrochromeno[3,4-d]imidazol-4(1H)-one derivatives as potent anticancer cell proliferation and migration agents.
Han X; Luo J; Wu F; Hou X; Yan G; Zhou M; Zhang M; Pu C; Li R
Eur J Med Chem; 2016 May; 114():232-43. PubMed ID: 26994691
[TBL] [Abstract][Full Text] [Related]
23. [Synthesis and bioactivities of novel dihydroartemisinin-piperazine derivatives containing sulfonamide].
Ma C; Li XQ; Xu J; Chen CX
Yao Xue Xue Bao; 2013 Sep; 48(9):1430-5. PubMed ID: 24358777
[TBL] [Abstract][Full Text] [Related]
24. Facile synthesis and anticancer activity of C-10 non-acetal deoxoartemisinin dimers.
Phothongkam S; Chancharunee S; Saovapakhiran A; Wichai U; Pohmakotr M
Bioorg Med Chem Lett; 2012 Dec; 22(24):7598-601. PubMed ID: 23103096
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and biological evaluation of novel hydroxamic acids bearing artemisinin skeleton.
Ha VT; Kien VT; Binh le H; Tien VD; My NT; Nam NH; Baltas M; Hahn H; Han BW; Thao do T; Vu TK
Bioorg Chem; 2016 Jun; 66():63-71. PubMed ID: 27018835
[TBL] [Abstract][Full Text] [Related]
26. Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro.
Zhou HJ; Zhang JL; Li A; Wang Z; Lou XE
Cancer Chemother Pharmacol; 2010 May; 66(1):21-9. PubMed ID: 19756601
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and biological evaluation of hydantoin bridged analogues of combretastatin A-4 as potential anticancer agents.
Zhang M; Liang YR; Li H; Liu MM; Wang Y
Bioorg Med Chem; 2017 Dec; 25(24):6623-6634. PubMed ID: 29126741
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and in vitro and in vivo antitumour activity of 3-benzylideneindolin-2-one derivatives, a novel class of small-molecule inhibitors of the MDM2-p53 interaction.
Zheng GH; Shen JJ; Zhan YC; Yi H; Xue ST; Wang Z; Ji XY; Li ZR
Eur J Med Chem; 2014 Jun; 81():277-88. PubMed ID: 24852275
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and antitumor activity of novel artemisinin derivatives using hybrid approach.
Xie L; Zhai X; Ren L; Meng H; Liu C; Zhu W; Zhao Y
Chem Pharm Bull (Tokyo); 2011; 59(8):984-90. PubMed ID: 21804243
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and structure-activity relationship studies of cytotoxic vinorelbine amide analogues.
Hu L; Song W; Meng Y; Guo D; Liu X; Hu L
Bioorg Med Chem Lett; 2012 Dec; 22(24):7547-50. PubMed ID: 23107481
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of D-ring fused 1,2,3-thiadiazole dehydroepiandrosterone derivatives as antitumor agents.
Cui HW; Peng S; Gu XZ; Chen H; He Y; Gao W; Lv F; Wang JH; Wang Y; Xie J; Liu MY; Yi Z; Qiu WW
Eur J Med Chem; 2016 Mar; 111():126-37. PubMed ID: 26866967
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and cytotoxic activity of new artemisinin hybrid molecules against human leukemia cells.
Letis AS; Seo EJ; Nikolaropoulos SS; Efferth T; Giannis A; Fousteris MA
Bioorg Med Chem; 2017 Jul; 25(13):3357-3367. PubMed ID: 28456567
[TBL] [Abstract][Full Text] [Related]
34. [Design, synthesis and antiproliferative activities of artemisinin derivatives substituted by N-heterocycles].
Zuo ZZ; Zhong H; Cai T; Bao Y; Liu ZQ; Liu D; Zhao LX
Yao Xue Xue Bao; 2015 Jul; 50(7):868-74. PubMed ID: 26552149
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and anticancer activities of novel otobain derivatives.
Li Z; Su H; Yu W; Li X; Cheng H; Liu M; Pang X; Zou X
Org Biomol Chem; 2016 Jan; 14(1):277-87. PubMed ID: 26593226
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity study of quinazoline derivatives leading to the discovery of potent EGFR-T790M inhibitors.
Zhang L; Yang Y; Zhou H; Zheng Q; Li Y; Zheng S; Zhao S; Chen D; Fan C
Eur J Med Chem; 2015 Sep; 102():445-63. PubMed ID: 26310890
[TBL] [Abstract][Full Text] [Related]
37. Combination of 2-methoxy-3-phenylsulfonylaminobenzamide and 2-aminobenzothiazole to discover novel anticancer agents.
Li H; Wang XM; Wang J; Shao T; Li YP; Mei QB; Lu SM; Zhang SQ
Bioorg Med Chem; 2014 Jul; 22(14):3739-48. PubMed ID: 24878359
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
[TBL] [Abstract][Full Text] [Related]
39. Design and Synthesis of Pyridazine Containing Compounds with Promising Anticancer Activity.
Elmeligie S; Ahmed EM; Abuel-Maaty SM; Zaitone SA; Mikhail DS
Chem Pharm Bull (Tokyo); 2017; 65(3):236-247. PubMed ID: 28250345
[TBL] [Abstract][Full Text] [Related]
40. Novel antitumor compound optimized from natural saponin Albiziabioside A induced caspase-dependent apoptosis and ferroptosis as a p53 activator through the mitochondrial pathway.
Wei G; Sun J; Hou Z; Luan W; Wang S; Cui S; Cheng M; Liu Y
Eur J Med Chem; 2018 Sep; 157():759-772. PubMed ID: 30142612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
